Regulators of G protein signalling: Potential targets for treatment of allergic inflammatory diseases such as asthma

Expert Opinion on Therapeutic Targets

Volumn 7, Issue 4, 2003, Pages 475-484

  Druey, Kirk M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Allergy; Asthma; Chemokines; G protein; RGS proteins

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; AUTACOID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; PROTEIN INHIBITOR; RGS PROTEIN;

AIRWAY OBSTRUCTION; ALLERGIC DISEASE; ANXIETY DISORDER; ASTHMA; CLINICAL FEATURE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG TARGETING; DYSPNEA; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LEUKOCYTE; LEUKOCYTE MIGRATION; LUNG PARENCHYMA; LYMPHOCYTE MIGRATION; MAST CELL; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TREMOR; WHEEZING;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; DRUG DESIGN; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; INFLAMMATION; MICE; MICE, TRANSGENIC; MULTIGENE FAMILY; RECEPTORS, G-PROTEIN-COUPLED; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0042329512     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.7.4.475     Document Type: Review

References (110)

1. TATTERSFIELD AE, KNOX AJ, BRITTON JR, HALL IP: Asthma. Lancet (2002) 360:1313-1322.
2. BUSSE WW, LEMANSKE RF: Asthma. N. Engl. J. Med. (2001) 344(5):350-362.
3. GOULD HJ, SUTTON BJ, BEAVIL AJ et al.: The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. (2002) E-published ahead of print.
4. KAWAKAMI T, GALLI SJ: Regulation of mast-cell and basophil survival by IgE. Nat. Rev. Immunol. (2002) 2:773-786.
5. BRIGHTLING CE, BRADDING P, SYMON FA, HOLGATE ST, WARDLAW AJ, PAVORD ID: Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. (2002) 346(22):1699-1705.
6. UMETSU D, MCINTIRE JJ, AKBARI O, MACAUBAS C, DEKRUYFF RH: Asthma: an epidemic of dysregulated immunity. Nat. Immunol. (2002) 3(8):715-720.
7. ZANGRILLI JG: Regulation of eosinophil viability by cytokines. Am. J. Respir. Cell Mol. Biol. (2002) 26(4):338-390.
8. DAVIES DE: The bronchial epithelium in chronic and severe asthma. Curr. Allergy Asthma Rep. (2002) 1(2):127-133.
9. VIGNOLA AM, GAGLIARDO R, SIENA A et al.: Airway remodeling in the pathogenesis of asthma. Curr. Allergy Asthma Rep. (2002) 1(2):108-115.
10. NILSSON G, JOHNELL M, HAMMER CH et al.: C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. (1996) 157(4):1693-1698.
11. JOLLY PS, ROSENFELDT HM, MILSTEIN S et al.: The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. (2001) 38:1239-1245.
12. HUMBLES AA, LU B, FRIEND DS et al.: The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA (2002) 99(3):1479-1484.
13. GONZALO JA, LLOYD CM, WEN D et al.: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. (1998) 188(1):157-167.
14. CYSTER JG: Chemokines and cell migration in secondary lymphoid organs. Science (1999) 286:2098-2102.
15. BLEASE K, LUKACS NW, HOGABOAM CM, KUNKEL SL: Chemokines and their role in airway hyperreactivity. Respir. Res. (2000) 1:54-61.
16. GUTIERREZ-RAMOS JC, LLOYD C, KAPSENBERG ML, GONZALO JA, COYLE AJ: Non-redundant functional groups of chemokines operate in a coordinate manner during the inflammatory response in the lung. Immunol. Rev. (2000) 177:31-42.
17. CYSTER JG, LUTHER SA: Chemokines as regulators of T cell differentiation. Nat. Immunol. (2001) 2(2):102-107.
18. LLOYD CM: Chemokines in allergic inflammation. Immunol. (2002) 105:144-154.
19. LUKACS NM: Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol. (2001) 1:108-116.
20. H2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J. Immunol. (2002) 169:651-655.
21. ROMAGNANI S: Cytokines and chemoattractants in allergic inflammation. Mol. Immunol. (2002) 38:881-885.
22. THIRSTRUP S: Control of airway smooth muscle tone. I - Electrophysiology and contractile mediators. Respir. Med. (2000) 94(4):328-336.
23. HART PH: Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell. Biol. (2001) 79(2):149-153.
24. DEVILLIER P, BACCARD N, ADVENIER C: Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors, and the role of leukotrienes in asthma. Pharmacol. Res. (2001) 40(1):3-13.
25. REYNOLDS PN, HOLMES MD, SCICCHITANO R: Role of tachykinins in bronchial hyper-responsiveness. Clin. Exp. Pharmacol. Physiol. (1997) 24(3-4):273-280.
26. PEISER C, UNDEM BJ, FISCHER A: Nociceptin effects in the airways. Peptides (2000) 21(7):995-998.
27. KRYMSKAYA VP, ORSINI MJ, ESZTERHAUS AJ et al: Mechanisms of proliferation synergy by receptor tyrosine kinase and G-protein-coupled receptor activation in human airway smooth muscle. Am. J. Respir. Cell Mol. Biol. (2000) 23:546-554.
28. HIRST SJ, WALKER TR, CHILVERS ER: Phenotypic diversity and molecular mechanisms of airway smooth muscle proliferation in asthma. Eur. Respir. J. (2000) 16:159-177.
29. EDIGER TL, DANFORTH BL, TOEWS ML: Lysophosphatidic acid upregulates the epidermal growth factor receptor in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. (2002) 282:L91-L98.
30. THIRSTRUP S: Control of airway smooth muscle tone. II - Pharmacology of relaxation. Respir. Med. (2000) 94(4):519-528.
31. DUTTA EJ, LI JT: β-agonists. Med. Clin. North Amer. (2002) 86(5):991-1008.
32. HALLSTRAND TS, HENDERSON WR Jr: Leukotriene modifiers. Med. Clin. North Amer. (2002) 86(5):1009-1103.
33. FLOWER DR: Modeling G-protein-coupled receptors for drug design. Biochim. Biophys. Acta. (1999) 1422:207-234.
34. SEARS MR: Asthma treatment: inhaled β-agonists. Can. Respir. J. (1998) 5(Suppl. A):A54-A59.
35. GILMAN AG: G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. (1987) 56:615-649.
36. MARINISSEN MJ, GUTKIND JS: G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharm. Sci. (2001) 22(7):368-376.
37. LANDRY Y, GIES JP: Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery. Mini Rev. Med. Chem. (2002) 2:361-372.
38. SAH VP, SEASHOLTZ TM, SAGI SA, BROWN JH: The role of Rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharm. Toxicol. (2000) 40:459-489.
39. KEHRL JH: Heterotrimeric G protein signaling: roles in the immune system and fine-tuning by RGS proteins. Immunity (1998) 8(1):1-10.
40. LOMBARDI MS, KAVELAARS A, HEIJNEN CJ: Role and modulation of G-protein-coupled receptor signaling in inflammatory process. Crit. Rev. Immunol. (2002) 22(2):141-163.
41. 2-adrenoceptor desensitization in vivo. J. Clin. Invest. (2000) 106:125-135.
42. + T cells of atopic asthmatic subjects. J. Asthma (2002) 39(5):441-448.
43. GRUNSTEIN MM, HAKONARSON H, WHELAN R, YU Z, GRUNSTEIN JS, CHUANG S: Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection. J. Allergy Clin. Immunol. (2001) 108:997-1004.
44. CHIBA Y, SAITOH N, MATSUO K, MASAWA M: Elevated nasal mucosal G protein levels and histamine receptor affinity in a guinea pig model of nasal hyperresponsiveness. Int. Arch. Allergy Immunol. (2002) 127:285-293.
45. BORCHERS MT, JUSTICE PJ, ANSAY T et al.: Gq signaling is required for allergen-induced pulmonary eosinophilia. J. Immunol. (2002) 168(7):3543-3549.
46. ROSS EM, WILKIE TM: GTPase activating proteins for heterotrimeric G proteins: regulators of G-protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. (2000) 69:795-827.
47. DE VRIES L, ZHENG B, FISCHER T, ELENKO K, FARQUHAR MG: The regulator of G-protein signaling family. Annu. Rev. Pharmacol. Toxicol. (2000) 40:235-271.
48. TESMER JJ, BERMAN DM, GILMAN AG, SPRANG SR: Crystal structure of RGS4 bound to AlF4-activated Giα1 - stabilization of the transition state for GTP hydrolysis. Cell (1997) 89(2):251-261.
49. NEUBIG RR, SIDEROVSKI DP: Regulators of G-protein signaling as new central nervous system drug targets. Nat. Rev. Drug Disc. (2002) 1(3):187-197.
50. ZHONG H, NEUBIG RR: Regulator of G protein signaling proteins: novel multifunctional drug targets. J. Pharmacol. Exp. Ther. (2001) 297(3):837-845.
51. FUKUHARA S, CHIKUMI H, GUTKIND JS: RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene (2001) 20(13):1661-1668.
52. ZHENG B, MA YC, OSTROM RS et al.: RGS-PX1, a GAP for Gαs and sorting nexin in vesicular trafficking. Science (2001) 294(5548):1939-1942.
53. MUKHOPADHYAY S, ROSS EM: Rapid GTP binding and hydrolysis by Gq promoted by receptor and GTPase-activating proteins. Proc. Natl. Acad. Sci. USA (1999) 96(17):9539-9544.
54. ZHONG H, WADE SM, WOOLF PJ, LINDERMAN JJ, TRAYNOR JR, NEUBIG RR: A spatial focusing model for G protein signals: RGS protein-mediated kinetic scaffolding. J. Biol. Chem. (2002) 278(9):7278-7284.
55. + channels. Proc. Natl. Acad. Sci. USA (1998) 95(20):11727-11732.
56. + channels. Eur. J. Biochem. (2000) 267(19 ):5830-5836.
57. KIMPLE RJ, DE VRIES L, TRONCHERE H et al.: RGS12 and RGS14 GoLoco motifs are Gαi-interaction sites with guanine nucleotide dissociation inhibitor activity. J. Biol. Chem. (2001) 276(31):29275-29281.
58. KIMPLE RJ, KIMPLE ME, BETTS L. SONDEK J, SIDEROVSKI DP: Structural determinants for GoLoco-induced inhibition of nucleotide release by Gα subunits. Nature (2002) 416(6883):878-881.
59. SONDEK J, SIDEROVSKI DP: Gγ-like (GGL) domains: new frontiers in G-protein signaling and β-propeller scaffolding. Biochem. Pharmacol. (2001) 61(11):1329-1337.
60. COWAN CW, HE W, WENSEL TG: RGS proteins: lessons from the RGS9 subfamily. Prog. Nucleic Acid Res. Mol. Biol. (2001) 65:341-359.
61. XU X, ZENG W, POPOV S et al.: RGS proteins determine signaling specificity of Gq-coupled receptors. J. Biol. Chem. (1999) 274(6):3549-3556.
62. SNOW BE, HALL RA, KRUMINS AM et al.: GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1 domain. J. Biol. Chem. (1998) 273(28):17749-17755.
63. WANG Q, LIU M, MULLAH B, SIDEROVSKI DP, NEUBIG RR: Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J. Biol. Chem. (2002) 277(28):24949-24958.
64. HEXIMER SP, SRINIVASA SP, BERNSTEIN LS et al.: G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. (1999) 274(48):34253-34259.
65. CLADMAN W, CHIDIAC P: Characterization and comparison of RGS2 and RGS4 as GTPase activating proteins for m2 muscarinic receptor-stimulated Gi. Mol. Pharm. (2002) 62(3):654-659.
66. SOWA ME, HE W, SLEP KC, KERCHER MA, LICHTARGE O, WENSEL TG: Prediction and confirmation of a site critical for effector regulation of RGS domain activity. Nat. Struct. Biol. (2001) 8(3):234-237.
67. LLOYD CM, DELANEY T, NGUYEN T et al.: CC chemokine receptor 3 (CCR3)/eotaxin is followed by CCR4/monocyte derived chemokine in mediating pulmonary T helper lymphocyte Type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. (2000) 191(2):265-274.
68. CHENSUE SW, LUKACS NW, YANG X et al.: Aberrant in vivo T helper Type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. (2001) 193(5):573-584.
69. GONZALO JA, LLOYD CM, PELED A, DELANEY T, COYLE AJ, GUTIERREZ-RAMOS JC et al.: Critical involvement of the chemotactic axis CXCR4/stromal cell-derived growth factor 1α in the inflammatory component of allergic airway disease. J. Immunol. (2000) 165(1):499-508.
70. CHAFFIN KE, PERELMUTTER RM: A pertussis toxin-sensitive process controls thymocyte emigration. Eur. J. Immunol. (1991) 21(10):2565-2573.
71. BOWMAN EP, CAMPBELL JJ, DRUEY KM, SCHESCHONKA A, KEHRL JH, BUTCHER EC: Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS family members. J. Biol. Chem. (1998) 273(43):28040-28048.
72. REIF K, CYSTER JG: RGS molecule expression in murine B lymphocytes and ability to downregulate chemotaxis to lymphoid chemokines. J. Immunol. (2000) 164:4720-4729.
73. BEADLING C, DRUEY KM, RICHTER GM, KEHRL JH, SMITH JA: Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes. J. Immunol. (1999) 162(5):2677-2682.
74. SCHESCHONKA A, DESSAUER CW, SINNARAJAH S, CHIDIAC P, SHI CS, KEHRL JH: RGS3 is a GTPase activating protein for Giα and Gqα and a potent inhibitor of signaling by GTPase-deficient forms of Gqα and G11α. Mol. Pharmacol. (2000) 58(4):719-728.
75. + T cells to CCL3 and CCL5. J. Immunol. (2002) 168(12):6263-6272.
76. CHO H, KOZASA T, TAKEKOSHI K, DE GUNZBERG J, KEHRL JH: RGS14, a GTPase activating protein for Giα, attenuates Giα- and G13α-mediated signaling pathways. Mol. Pharmacol. (2000) 58(3 ):569-576.
77. FONG CW, ZHANG Y, NEO SY, LIN SC: Specific induction of RGS16 mRNA by protein kinase C in CEM leukaemia cells is mediated via tumour necrosis factor α in a calcium sensitive manner. Biochem. J. (2000) 352(3):747-753.
78. MORATZ C, KANG VH, DRUEY KM et al.: Regulator of G protein signaling 1 (RGS1) markedly impairs Giα signaling responses of B lymphocytes. J. Immunol. (1999) 164:1829-1838.
79. ZHU Y, HOLLMEN J, RATY R et al.: Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br. J. Haematol. (2002) 119(4):905-915.
80. JOHNSON EN, DRUEY KM: Functional characterization of the G protein regulator RGS13. J. Biol. Chem. (2002) 277(19):16768-16774.
81. SHI GX, HARRISON K, WILSON GL, MORATZ C, KEHRL JH: RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligands CXCL12 and CXCL13. J. Immunol. (2002) 169:2507-2515.
82. DRUEY KM, BLUMER KJ, KANG VH, KEHRL JH: Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature (1996) 379(6567):742-746.
83. GIRKONTAITE I, MISSY K, SAKK A et al.: Lsc is required for marginal zone B cells, regulation of lymphocyte motility, and immune responses. Nat. Immunol. (2001) 2(9):855-862.
84. OLIVEIRA-DOS-SANTOS AJ, MATUSMOTO G, SNOW BE et al.: Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc. Natl. Acad. Sci. USA (2000) 97(22):11272-12277.
85. WILLS-KARP M, LUYIMBAZI J, XU X et al.: Interleukin-13: central mediator of allergic asthma. Science (1998) 282:2258-2261.
86. KUPERMAN DA, HUANG X, KOTH LL et al.: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. (2002) 8(8):885-889.
87. WARDLAW AJ, BRIGHTLING CE, GREEN R, WOLTMANN G, BRADDING P, PAVORD ID: New insights into the relationship between airway inflammation and asthma. Clin. Sci. (2002) 103:201-211.
88. JOHNSON EN, DRUEY KM: Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J. Allergy Clin. Immunol. (2002) 109:592-602.
89. DE VRIES L, MOUSLI M, WURMSER A, FARQUHAR MG: GAIP, a protein that specifically interacts with Gαi3, is a member of a protein family with a highly conserved core domain. Proc. Natl. Acad. Sci. USA (1995) 92(25):11916-11920.
90. HONG JX, WILSON GL, FOX CH, KEHRL JH: Isolation and characterization of a novel B cell activation gene. J. Immunol. (1993) 150(9):3895-3904.
91. NLEND MC, BOOKMAN RJ, CONNER GE, SALATHE M: Regulator of G protein signaling protein 2 modulates purinergic calcium and ciliary beat frequency responses in airway epithelia. Am. J. Respir. Cell. Mol. Biol. (2002) 27(4):436-445.
92. NOMOTO S, ADACHI K, TANG LX, HIRATA Y, MURAGUCHI S, KIUCHI K: Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization. Biochem. Biophys. Res. Commun. (1997) 18(2):281-287.
93. SEKI N, SUGANO S, SUZUKI Y et al.: Isolation, tissue expression, and chromosomal assignment of human RGS5, a novel G-protein signaling regulator gene. J. Hum. Genet. (1998) 43(3):202-205.
94. CHO H, KOZASA T, BONDJERS C, BETSHOLTZ C, KEHRL JH: Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J. (2003) 17(3):440-442.
95. HALLER C, FILLATEAU S, HOFFMAN R, AGENES F: Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling 10 gene (mRGS10). Gene (2002) 297(1-2):39-49.
96. SNOW BE, ANTONIO L, SUGGS S, GUTSTEIN HC, SIDEROVSKI DP: Molecular cloning and expression analysis of rat Rgs12 and Rgs14. Biochem. Biophys. Res. Commun. (1997) 233:770-777.
97. HEXIMER S, KNUTSEN RH, SUN X et al.: Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. (2003) 111(4):445-452.
98. MIRNICS K, MIDDLETON FA, STANWOOD GD, LEWIS DA, LEVITT P: Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psych. (2001) 6(3):293-301.
99. 2a-adrenoceptor agonist-stimulated GTPase activity of Go1α. J. Neurochem. (2001) 78:797-806.
100. WIELAND T, BAHTIJARI N, ZHOU XB, KLEUSS C, SIMON MI: Polarity exchange at the interface of regulators of G protein signaling with G protein α-subunits. J. Biol. Chem. (2000) 275(37):28500-28506.
101. HOPKINS AL, GROOM CR: The druggable genome. Nat. Rev. Drug. Disc. (2002) 1:727-730.
102. HOLLINGER S, HEPLER JR: Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. (2002) 54(3):527-559.
103. DENECKE B, MEYERDIERKS A, BOTTGER EC: RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemo-attractant receptors. J. Biol. Chem. (1999) 274(38):26860-26888.
104. SINNARAJAH S, DESSAUER CW, SRIKUMAR D et al.: RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature (2001) 409(6823):1051-1055.
105. SHI CS, LEE SB, SINNARAJAH S, DESSAUER CW, RHEE SG, KEHRL JH: RGS3 inhibits Gβ1γ2-induced inositol phosphate production, MAP kinase activation, and Akt activation. J. Biol. Chem. (2001) 276(26):24293-24300.
106. MAO J, YUAN H, XIE W, SIMON MI, WU D: Specific involvement of G proteins in regulation of serum response factor-mediated gene transcription by different receptors. J. Biol. Chem. (1998) 273(42):27118-27223.
107. TRAVER S, BIDOT C, SPASKY N et al.: RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of Gαo. Biochem. J. (2000) 350:19-29.
108. CARMAN CV, PARENT JL, DAY PW et al.: Selective regulation of Gαq/11 by an RGS domain in the G-protein-coupled receptor kinase, GRK2. J. Biol. Chem. (1999) 274(48):34483-34492.
109. DE BLASI A, PARRUTI G, SALLESE M: Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of β-adrenergic receptor kinase 1 and 2. J. Clin. Invest. (1995) 95(1):203-210.
110. LOMBARDI MS, KAVELAARS A, SCHEDLOWSKI M et al.: Decreased expression of G-protein-coupled receptor kinases in peripheral blood mononuclear cells patients with rheumatoid arthritis. FASEB J. (1999) 13(6):715-725.